Literature DB >> 22135603

Towards the prevention and management of prostatic diseases in Nigeria: a framework.

Chukwunonso Ecc Ejike1.   

Abstract

The prevalence of prostatic diseases is reportedly high in Nigeria, and in some cases, it is comparable to figures from industrialised countries. However, to date, the research and policy responses in Nigeria are regrettably inadequate. The presence of "the double burden of diseases" and a limited appreciation of recent trends in prostatic diseases may be partly responsible for this situation. Given the frequently meagre healthcare budgetary allocations, it is pertinent to develop a properly thought-out plan for the prevention and management of prostatic diseases in Nigeria. A framework aimed at contributing to the development of such a plan is presented here. The development of a Central Prostatic Diseases Unit (CPDU) in the Federal Ministry of Health is advocated. The CPDU would be responsible for planning research and information dissemination programmes. Emphasis should be placed on targeting modifiable risk factors at the population level, proper surveillance to identify emerging trends, and research on both the operational dynamics and the efficacy of locally available herbs that could be useful in the management of prostatic diseases.

Entities:  

Keywords:  Nigeria; disease management; health planning; prevention; prostatic diseases; public health

Year:  2011        PMID: 22135603      PMCID: PMC3216219     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  41 in total

Review 1.  Phytotherapy in the treatment of benign prostatic hyperplasia: an update.

Authors:  F C Lowe; E Fagelman
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

2.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

3.  Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

Authors:  J Hammarsten; B Högstedt
Journal:  Eur Urol       Date:  2001-02       Impact factor: 20.096

4.  Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study.

Authors:  A Mehik; P Hellström; O Lukkarinen; A Sarpola; M Järvelin
Journal:  BJU Int       Date:  2000-09       Impact factor: 5.588

5.  Pumpkin seed oil and phytosterol-F can block testosterone/prazosin-induced prostate growth in rats.

Authors:  Yuh-Shyan Tsai; Yat-Ching Tong; Juei-Tang Cheng; Chung-Ho Lee; Fu-Shan Yang; Hua-Yang Lee
Journal:  Urol Int       Date:  2006       Impact factor: 2.089

Review 6.  Pygeum africanum for benign prostatic hyperplasia.

Authors:  T Wilt; A Ishani; R Mac Donald; I Rutks; G Stark
Journal:  Cochrane Database Syst Rev       Date:  2002

7.  Physical activity and benign prostatic hyperplasia.

Authors:  E A Platz; I Kawachi; E B Rimm; G A Colditz; M J Stampfer; W C Willett; E Giovannucci
Journal:  Arch Intern Med       Date:  1998-11-23

8.  Prevalence of chronic prostatitis symptoms in a randomly surveyed adult population of urban-community-dwelling Nigerian males.

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int J Urol       Date:  2008-04       Impact factor: 3.369

9.  Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int Urol Nephrol       Date:  2008-02-21       Impact factor: 2.370

10.  The impact of diabetes type 2 in the pathogenesis of benign prostatic hyperplasia: a review.

Authors:  K Stamatiou; M Lardas; E Kostakos; V Koutsonasios; E Michail
Journal:  Adv Urol       Date:  2009-11-09
View more
  1 in total

1.  Awareness and Attitudes of Nigerian Men Living in Abuja on Prostate Cancer and Screening.

Authors:  Paraskevi A Farazi; Mohammad Siahpush; Shannon Maloney; Danae Dinkel; Arthur Michalek; Rahama John; Olabode Oluwole
Journal:  J Cancer Educ       Date:  2019-12       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.